These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38179315)

  • 1. Sclerotherapy with 3% polidocanol foam in the treatment of hemorrhoidal disease: unveiling the missing pieces for a comprehensive evaluation.
    Gallo G; Dezi A; Grossi U; Picciariello A
    Front Surg; 2023; 10():1344724. PubMed ID: 38179315
    [No Abstract]   [Full Text] [Related]  

  • 2. Polidocanol Foam Sclerotherapy Versus Rubber Band Ligation in Hemorrhoidal Disease Grades I/II/III: Randomized Trial.
    Salgueiro P; Garrido M; Santos RG; Pedroto I; Castro-Poças FM
    Dis Colon Rectum; 2022 Jul; 65(7):e718-e727. PubMed ID: 34840294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sclerotherapy using 2 % polidocanol foam in the treatment of hemorrhoidal disease - a single-center experience.
    Figueiredo LM; Bordalo Ferreira F; Rafael MA; Oliveira AM
    Rev Esp Enferm Dig; 2022 Mar; 114(3):185-186. PubMed ID: 34517712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polidocanol foam sclerotherapy in the treatment of hemorrhoidal disease in patients with bleeding disorders: a multicenter, prospective, cohort study.
    Salgueiro P; Rei A; Garrido M; Rosa B; Oliveira AM; Pereira-Guedes T; Morais S; Castro-Poças F
    Tech Coloproctol; 2022 Aug; 26(8):615-625. PubMed ID: 35217937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-Term Results of Sclerotherapy with 3% Polidocanol Foam for Symptomatic Second- and Third-Degree Hemorrhoidal Disease.
    Lobascio P; Laforgia R; Novelli E; Perrone F; Di Salvo M; Pezzolla A; Trompetto M; Gallo G
    J Invest Surg; 2021 Oct; 34(10):1059-1065. PubMed ID: 32290709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3% polidocanol foam sclerotherapy versus hemorrhoidal artery ligation with recto anal repair in hemorrhoidal disease grades II-III: a randomized, pilot trial.
    Neves S; Falcão D; Povo A; Castro-Poças F; Oliveira J; Salgueiro P
    Rev Esp Enferm Dig; 2023 Mar; 115(3):115-120. PubMed ID: 35638762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.
    Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S
    Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy with 3% polidocanol foam for third- and fourth-degree hemorrhoids as "bridge treatment" during the COVID-19 pandemic in Italy.
    Lisi G; Campanelli M; Grande S; Milito G; Grande M
    Int J Colorectal Dis; 2021 Jun; 36(6):1321-1322. PubMed ID: 33452908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicentre, open-label, single-arm phase II trial of the efficacy and safety of sclerotherapy using 3% polidocanol foam to treat second-degree haemorrhoids (SCLEROFOAM).
    Gallo G; Pietroletti R; Novelli E; Sturiale A; Tutino R; Lobascio P; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Luc AR; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; Sammarco G
    Tech Coloproctol; 2022 Aug; 26(8):627-636. PubMed ID: 35334004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotherapy for hemorrhoidal disease: systematic review and meta-analysis.
    Gallo G; Picciariello A; Armellin C; Lori E; Tomasicchio G; Di Tanna GL; Santoro GA; Alharbi M; Sorrenti S; Grossi U
    Tech Coloproctol; 2024 Jan; 28(1):28. PubMed ID: 38261136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
    Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P
    Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary Results of the First 50 Patients Undergoing Sclerotherapy for II-Degree Hemorrhoidal Disease Using an Automated Device.
    Goglia M; Nigro C; Aurello P; Diaco E; Trompetto M; Gallo G
    Front Surg; 2022; 9():882030. PubMed ID: 35495738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HEmoRhoidal disease management with Band ligation versus polidocanol Sclerotherapy: a systematic review and meta-analysis (the HerBS Review).
    Patel J; McKechnie T; Wu K; Sharma S; Lee Y; Doumouras A; Hong D; Eskicioglu C
    Int J Colorectal Dis; 2023 May; 38(1):112. PubMed ID: 37133577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes.
    Pata F; Bracchitta LM; D'Ambrosio G; Bracchitta S
    J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sclerotherapy of internal hemorrhoids using newly devised transparent disposable anorectoscope.
    Inoue H; Takemura K; Hori H; Itoh K; Muraoka Y; Yoneshima H; Endo M
    Surg Endosc; 1992; 6(3):125-7. PubMed ID: 1502679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of sclerotherapy with polidocanol in children with internal hemorrhoids.
    Watanabe T; Ohno M; Tahara K; Tomonaga K; Ogawa K; Takezoe T; Fuchimoto Y; Fujino A; Kanamori Y
    Pediatr Int; 2021 Jul; 63(7):813-817. PubMed ID: 33045763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease - a video vignette.
    Lobascio P; Minafra M; Laforgia R; Giove C; Trompetto M; Gallo G
    Colorectal Dis; 2019 Feb; 21(2):244-245. PubMed ID: 30485654
    [No Abstract]   [Full Text] [Related]  

  • 18. Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial.
    Mishra S; Sahoo AK; Elamurugan TP; Jagdish S
    Turk J Gastroenterol; 2020 May; 31(5):378-383. PubMed ID: 32519957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of video-guided sclerotherapy with 3% polidocanol foam for symptomatic second-degree haemorrhoidal disease - a video vignette.
    Skowronski A; Diaco E; Trompetto M; Gallo G
    Colorectal Dis; 2020 Sep; 22(9):1198-1199. PubMed ID: 32180308
    [No Abstract]   [Full Text] [Related]  

  • 20. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients.
    Chung SH; Lee MS; Kim KS; Kim SI; Won JY; Lee DY; Lee KH
    Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1236-43. PubMed ID: 21290126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.